Thousands of people to receive cannabis as a painkiller in a major new trial that could pave the way for its prescription
Epidiolex
HSE approves reimbursement for CBD drug Epidiolex HSE has confirmed that Epidiolex will be reimbursed by the state for patients
Jazz Pharma buys GW Pharma for $ 7,2 billion, adding cannabis drug to its portfolio Huge deal: Jazz Pharma acquires
FDA approves Epidiolex for genetic syndrome of tuberous sclerosis New FDA approval, granted July 31 in the United States, validates
UK Home Office reclassified Epidiolex as Schedule 5 drug GW Pharmaceuticals' epidiolex (cannabidiol) moved from Schedule 2 to Schedule
Marinol or synthetic THC? This drug was first approved by the Food and Drug Administration (FDA) in 1985. At this time
DDB clarifies: CBD is not cannabis per se It's a small step, but it's practically a foot in the door. Supporters
Tuberous Sclerosis Severe Tuberculosis Treatment A highly purified oral solution of cannabidiol (CBD) reduces by more than a third
The NHS (National Health Service) has approved the use of Epidiolex and Sativex Thousands of patients will receive treatment based on
Epidyolex is the first cannabis drug to receive the green light from regulatory agencies in the UK and EU. The first
GW Pharma's Epidiolex approved by the European Medicines Agency The Committee for Medicinal Products for Human Use (CHMP), a body of the European Medicines Agency